182 related articles for article (PubMed ID: 23597147)
1. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion.
Shah AA; Schiopu E; Hummers LK; Wade M; Phillips K; Anderson C; Wise R; Boin F; Seibold JR; Wigley F; Rollins KD
Arthritis Res Ther; 2013 Apr; 15(2):R54. PubMed ID: 23597147
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers.
Jones A; Wang-Smith L; Pham T; Laliberte K
J Cardiovasc Pharmacol; 2014 Mar; 63(3):227-32. PubMed ID: 24603117
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension.
White RJ; Torres F; Allen R; Jerjes C; Pulido T; Yehle D; Howell M; Laliberte K; Marier JF; Tapson VF
J Cardiovasc Pharmacol; 2013 Jun; 61(6):474-81. PubMed ID: 23328389
[TBL] [Abstract][Full Text] [Related]
4. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept study.
Roustit M; Gaillard-Bigot F; Blaise S; Stanke-Labesque F; Cracowski C; Seinturier C; Jourdil JF; Imbert B; Carpentier PH; Cracowski JL
Clin Pharmacol Ther; 2014 Apr; 95(4):439-45. PubMed ID: 24458011
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of treprostinil diolamine in subjects with end-stage renal disease on or off dialysis.
Jenkins A; Wang-Smith L; Marbury T; Laliberte K
J Cardiovasc Pharmacol; 2013 Apr; 61(4):272-6. PubMed ID: 23188123
[TBL] [Abstract][Full Text] [Related]
7. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
[TBL] [Abstract][Full Text] [Related]
8. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
Shah AA; Schiopu E; Chatterjee S; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V
J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
[TBL] [Abstract][Full Text] [Related]
9. Treprostinil Hydrogel Iontophoresis in Systemic Sclerosis-Related Digital Skin Ulcers: A Safety Study.
Guigui A; Mazet R; Blaise S; Cracowski C; Beau-Guillaumot M; Kotzki S; Roustit M; Cracowski JL
J Clin Pharmacol; 2020 Jun; 60(6):758-767. PubMed ID: 32080862
[TBL] [Abstract][Full Text] [Related]
10. Cathodal iontophoresis of treprostinil induces a sustained increase in cutaneous blood flux in healthy volunteers.
Blaise S; Roustit M; Hellmann M; Millet C; Cracowski JL
J Clin Pharmacol; 2013 Jan; 53(1):58-66. PubMed ID: 23400744
[TBL] [Abstract][Full Text] [Related]
11. Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers.
Gotzkowsky SK; Dingemanse J; Lai A; Mottola D; Laliberte K
J Clin Pharmacol; 2010 Jul; 50(7):829-34. PubMed ID: 20133511
[TBL] [Abstract][Full Text] [Related]
12. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.
Engel G; Rockson SG
Vasc Med; 2005 Feb; 10(1):29-32. PubMed ID: 15920997
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment.
Peterson L; Marbury T; Marier J; Laliberte K
J Clin Pharm Ther; 2013 Dec; 38(6):518-23. PubMed ID: 24033615
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
Wade M; Baker FJ; Roscigno R; DellaMaestra W; Arneson CP; Hunt TL; Lai AA
J Clin Pharmacol; 2004 May; 44(5):503-9. PubMed ID: 15102871
[TBL] [Abstract][Full Text] [Related]
15. Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats.
Blaise S; Roustit M; Millet C; Ribuot C; Boutonnat J; Cracowski JL
Br J Pharmacol; 2011 Feb; 162(3):557-65. PubMed ID: 20860718
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration.
Kumar P; Thudium E; Laliberte K; Zaccardelli D; Nelsen A
Clin Pharmacokinet; 2016 Dec; 55(12):1495-1505. PubMed ID: 27286723
[TBL] [Abstract][Full Text] [Related]
17. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
18. Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
McSwain CS; Benza R; Shapiro S; Hill N; Schilz R; Elliott CG; Zwicke DL; Oudiz RJ; Staszewski JP; Arneson CP; Wade M; Zaccardelli D; McLaughlin V
J Clin Pharmacol; 2008 Jan; 48(1):19-25. PubMed ID: 18094217
[TBL] [Abstract][Full Text] [Related]
19. The role of treprostinil in the management of pulmonary hypertension.
Skoro-Sajer N; Lang I
Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
[TBL] [Abstract][Full Text] [Related]
20. Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis.
Gaillard-Bigot F; Roustit M; Blaise S; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
Microcirculation; 2016 Apr; 23(3):266-70. PubMed ID: 26833587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
